author-photo

Luis E. Arias-Romero

National Autonomous University of Mexico

29

Papers

862

Citations

Citation Trend

Filter By

Papers (15) Sort By

Journal Conference Others

Recent advances in PTP1B signaling in metabolism and cancer.

2021 Bioscience Reports
Show All
- Source
- Cite
- Save
Citations (0)
IFI27/ISG12 Downregulates Estrogen Receptor α Transactivation by Facilitating Its Interaction With CRM1/XPO1 in Breast Cancer Cells

2020 Frontiers in Endocrinology
Show All
- Source
- Cite
- Save
Citations (4)
Helminth‐derived molecules inhibit colitis‐associated colon cancer development through NF‐kB and STAT3 regulation

2019 International Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (15)
Reduced PAK1 activity sensitizes FA/BRCA-proficient breast cancer cells to PARP inhibition

2016 Oncotarget
Show All
- Source
- Cite
- Save
Citations (11)
H-ras Inhibits the Hippo Pathway by Promoting Mst1/Mst2 Heterodimerization

2016 Current Biology
Show All
- Source
- Cite
- Save
Citations (20)
Abstract B31: Pak1 and β-catenin inhibition blocks tumor progression in ErbB2-driven breast cancer models

2013 Molecular Cancer Therapeutics
Show All
- Source
- Cite
- Save
Citations (0)
Phosphoproteomics for the Mapping of Altered Cell Signaling Networks in Breast Cancer

2013
- Olga Villamar-Cruz
- Luis E. Arias-Romero
Show All
- Source
- Cite
- Save
Citations (1)
Pak1 Kinase Links ErbB2 to β-Catenin in Transformation of Breast Epithelial Cells

2013 Cancer Research
Show All
- Source
- Cite
- Save
Citations (60)
Targeting Cdc42 in cancer.

2013 Expert Opinion on Therapeutic Targets
- Luis E. Arias-Romero
- Jonathan Chernoff
Show All
- Source
- Cite
- Save
Citations (57)
p21-activated kinases in Erbb2-positive breast cancer: A new therapeutic target?

2010 Small GTPases
- Luis E. Arias-Romero
- Jonathan Chernoff
Show All
- Source
- Cite
- Save
Citations (25)